When we compared CP expression in different prostate cancer cell lines by Western blotting, we observed slightly lower levels of CAPZA1 in PC-3 cells as compared to the other lines, while CAPZB levels were highest in DU-145 cells (Additional file 3: Fig. S10A). This evidence concerns the gene CAPZB and prostate carcinoma.